Welcome to GRACE






    Home

    Overview

    Confidentiality

    Bibliography

    Advisors

    Resources

    Members Room



    
   

GRACE Bibliography -


Easily printable version (requires Adobe Acrobat)
GRACE Appendix (requires Adobe Acrobat)
Manuscripts
Non-GRACE publications
‘Expanded’ GRACE publications
Abstracts

Manuscripts

2008
  1. Devlin D, Gore JM, Elliott J, Wijesinghe N, Eagle KA, Avezum Á, Huang W, Brieger D, for the GRACE Investigators. Management and 6-month outcomes in elderly and very elderly patients with high-risk non?ST-elevation acute coronary syndromes. The Global Registry of Acute Coronary Events. Eur Heart J 2008; doi:10.1093/eurheartj/ehn124.
  2. Dey S, Flather MD, Devlin G, Brieger D, Gurfinkel EP, Steg PhG, FitzGerald G, Jackson EA, Eagle KA, for the GRACE investigators. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Heart 2008 (in press).
  3. Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, López-Sendón J, Goodman SG, Quill A, Fox KAA, for the Global Registry of Acute Coronary Events (GRACE) Investigators. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008 (in press).
  4. Yan RT, Yan AT, Granger CB, Lopez-Sendon J, Brieger D, Kennelly B, Budaj A, Steg PhG, Georgescu AA, Hassan Q, Goodman SG, on behalf of the Global Registry of Acute Coronary Events (GRACE) Electrocardiogram Substudy Group. Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. Am J Cardiol 2008 (in press).

2007

  1. Brieger D, Elsik M, Gore JM, Knobel E, Nussbacher A, Piegas LS, Allegrone J, Anderson FA, Avezum Á, on behalf of the Global Registry of Acute Coronary Events investigators. Predicting coronary artery bypass graft surgery in acute coronary syndromes. EuroIntervention 2007;2:452–458.
  2. Brieger D, Van de Werf F, Avezum Á, Montalescot G, Kennelly BM, Granger CB, Goodman SG, Dabbous OH, Agnelli G, for the GRACE Investigators. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events. Am Heart J 2007;153:960-9.
  3. Dabbous OH, Anderson FA, Jr, Gore JM, Eagle KA, Fox KAAF, Mehta RH, Goldberg RJ, Agnelli G, Steg PG, for the GRACE Investigators. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. Heart, Jun 2007; doi:10.1136/hrt.2006.105783.
  4. Fox KAA, Anderson Jr FA, Dabbous OH, Steg PhG, López-Sendón J, Van de Werf F, Budaj A, Gurfinkel EP, Goodman SG, Brieger D, on behalf of the GRACE Investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007;93:177-82.
  5. Fox KAA, Steg PG, Eagle KA, Goodman SG, Anderson FA, Granger CB, Flather MD, Budaj A, Quill A, Gore JM, for the GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999 to 2006. JAMA 2007;297:1892-1900.
  6. Gore JM, Spencer FA, Goldberg RJ, Kennelly BM, Fox KAA, Allegrone J, Eagle KA, Anderson FA, Steg PG, on behalf of the GRACE Investigators. Use of heparins in non-ST-elevation acute coronary syndromes. Am J Med 2007:120:63-71.
  7. Goldberg RJ, Spencer FA, Steg PG, Flather MD, Montalescot G, Gurfinkel EP, Kennelly BM, Goodman SG, Dedrick R, Gore JM, for the GRACE Investigators. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. Arch Intern Med 2007;167:1766-1773.
  8. Gurfinkel EP, Perez de la Hoz R, Brito VB, Duronto E, Dabbous OH, Gore JM, Anderson FA, for the GRACE Investigators. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery. Int J Cardiol 2007; 119:65-72.
  9. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G, Budaj A, Avezum Á, Allegrone J, FitzGerald G, Steg PG, on behalf of the GRACE Investigators. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 2007;100:1-6.
  10. Nallamothu BK, Fox KAA, Kennelly BM, Van de Werf F, Gore JM, Steg PG, Granger CB, Dabbous OH, Kline-Rogers E, Eagle KA, on behalf of the GRACE Investigators. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart 2007 doi:10.1136/hrt.2006.112847.
  11. Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D, for the GRACE Investigators. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 2007. doi:10.1093/eurheartj/ehm186.
  12. Oliveira GBF, Avezum Á, Frederick FA, Budaj A, Dabbous OH, Goodman SG, Steg PG, Goldberg RJ, Brieger D, Fox KAA, Gore JM, Granger CB, for the GRACE Investigators. Use of proven therapies in non–ST-elevation acute coronary syndromes according to evidence-based risk stratification. Am Heart J 2007;153:493-9.
  13. Ramsay G, Podogrodzka M, McClure C, Fox KAA. Risk prediction in patients presenting with suspected cardiac pain: the GRACE and TIMI risk scores versus clinical evaluation. QJM 2007 100(1):11-18; doi:10.1093/qjmed/hcl133.
  14. Spencer FA, Goldberg RJ, Gore JM, Fox KAA, Avezum Á, Agnelli G, Kritharides L, Anderson FA, Goodman SG, FitzGerald G, Allegrone J, Brieger D, for the GRACE Investigators. Comparison of utilization of statin therapy at hospital discharge and 6-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein =100 mg/dl versus <100 mg/dl. Am J Cardiol 2007;100:913–918.
  15. Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, Goodman SG, Budaj A, FitzGerald G, Fox KAA, for the GRACE Investigators. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 2007;116:2793-801.
  16. Steg PG, López-Sendón J, Lopez de Sa E, Goodman SG, Gore JM, Anderson FA, Himbert D, Allegrone J, Van de Werf F, for the GRACE Investigators. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007;167:68-73.
  17. Stiles M, Dabbous OH, Fox KAA, on behalf of the GRACE Investigators. Bleeding events with antithrombotic therapy in patients with unstable angina or non-ST-segment elevation myocardial infarction; insights from a large clinical practice registry (GRACE). Heart, Lung and Circulation 2007 (Epub ahead of print).
  18. Yan RT, Yan AT, Allegrone J, López-Sendón J, Granger CB, Gore JM, Budaj A, Georgescu AA, Hassan Q, Luchansky J, Van de Werf F, Goodman SG, on behalf of the Global Registry of Acute Coronary Events (GRACE) Electrocardiogram Substudy Group. Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcome. Am J Cardiol 2007;100:169-74.
  19. Yan A, Yan RT, Goodman SG, Kennelly BM, Anderson Jr., Budaj A, López-Sendón J, Brieger D, Allegrone J, Steg PG, Goodman SG, for the GRACE Investigators. Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes. Am Heart J 2007;154:71-8.
2006
  1. Emery M, López-Sendón J, Steg PG, Anderson FA, Jr., Dabbous OH, Scheuble A, Eagle KA. Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events. Am Heart J 2006;152:1015-1021.
  2. Fox KAA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum Á, Goodman SG, Flather MD, Anderson Jr, FA, Granger CB, for the GRACE Investigators. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br Med J 2006;333:1091-4. doi:10.1136/bmj.38985.646481.55 (published 10 October 2006)
  3. Froehlich JB, Mukherjee D, Avezum Á, Budaj A, Kline-Rogers EM, López-Sendón J, Agnelli G, Allegrone J, Eagle KA, Mehta RH, Goldberg RJ, for the GRACE Investigators. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006;151:1123-8.
  4. Goodman SG, Steg PG, Eagle KA, Fox KAA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP, for the GRACE Investigators. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006;151:654-60.
2005
  1. Avezum Á, Makdisse M, Spencer F, Gore JM, Fox KAA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet J-P, for the GRACE Investigators. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005;149:67-73.
  2. Budaj A, Flasinska K, Gore JM, Anderson FA, Dabbous OH, Spencer FA, Goldberg RJ, Fox KAA, on behalf of the GRACE Investigators. Magnitude of and risk factors for stroke in patients with acute coronary syndromes. Findings from a Global Registry of Acute Coronary Events. Circulation 2005; 111:3242-7.
  3. Carruthers KF, Dabbous OH, Flather MD, Starkey I, Jacob A, MacLeod D, Fox KAA, on behalf of the GRACE Investigators. Contemporary management of acute coronary syndromes: does the practice match the evidence? The Global Registry of Acute Coronary Events (GRACE). Heart 2005;91:290-8.
  4. Collet JP, Montalescot G, Agnelli G, Van de Werf F, Gurfinkel EP, López-Sendón J, Laufenberg CV, Klutman M, Gowda N, Gulba D, for the GRACE Investigators. Non-ST-segment elevation acute coronary syndrome in patients with renal failure in the Global Registry of Acute Coronary Events: benefit of low-molecular-weight heparin alone and with glycoprotein IIb/IIIa inhibitors on outcomes. Eur Heart J 2005; doi:10.1093/eurheartj/ehj337.
  5. Devlin GP, Anderson Jr FA, Heald S, López-Sendón J, Avezum Á, Elliott J, Dabbous OH, and Brieger D. Management and outcomes of lower-risk patients presenting with acute coronary syndromes in a multinational observational registry. Heart 2005; doi:10.1136/hrt.2004.054007
  6. Granger CB, López-Sendón J, Van de Werf F, Kline-Rogers E, Anderson FA, Dabbous OH, Allegrone J, Klein W, Eagle KA. Medication performance measures and mortality following acute coronary syndromes. Am J Med 2005;118:858-65.
  7. Gurfinkel EP, Bozovich GE, Dabbous O, Mautner B, Anderson F. Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina. Thromb J. 2005;3:22.
  8. Himbert D, Klutman M, Steg PhG, White K, Gulba DC, for the GRACE Investigators. Cigarette smoking and acute coronary syndromes: a multinational observational study. Int J Cardiol 2005; 100:109-17.
  9. Lim MJ, Eagle KA, Gore JM, Goldberg RJ, Mehta RJ, Granger CB, Anderson FA, Flather M, Dabbous OH, Spencer FA. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol 2005;96:917-21.
  10. Lim MJ, Spencer FA, Gore JM, Dabbous OH, Agnelli G, Kline-Rogers EM, DiBenedetto D, Eagle KA, Mehta RH, for the GRACE Investigators. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes. Perspectives from a large multinational registry. Eur Heart J 2005; doi: 10.1093/eurheartj/ehi139.
  11. Mallat Z, Steg PG, Benessiano J, Tanguy ML, Fox KA, Collet JP, Dabbous OH, Henry P, Carruthers KF, Dauphin A, Arguelles CS, Masliah J, Hugel B, Montalescot G, Freyssinet JM, Asselain B, Tedgui A. Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes. J Am Coll Cardiol 2005;46:1249-1257.
  12. Montalescot G, Dabbous OH, Lim MJ, Flather MD, Mehta RH, for the GRACE Investigators. Relation of timing of cardiac catheterization to outcomes in patients with non-ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational Global Registry of Acute Coronary Events. Am J Cardiol 2005; 95:1397-1403.
  13. Van de Werf F, Gore JM, Avezum Á, Gulba DC, Goodman SG, Budaj A, Brieger D, White K, Fox KAA, Eagle KA, Kennelly BM, and for the GRACE Investigators. Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. Br Med J 2005;330:441.
2004
  1. Brieger D, Eagle KA, Goodman SG, Steg PhG, Budaj A, White K, Montalescot G, for the GRACE Investigators. Acute coronary syndromes without chest pain: an underdiagnosed and undertreated high-risk group. Insights from the Global Registry of Acute Coronary Events (GRACE). Chest 2004;126:461-69.[Medline] [Free full text]
  2. Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum Á, Flather MD, Granger CB, Erickson S, White K, Steg PhG, for the GRACE Investigators. Adherence to evidence-based therapies after discharge for acute coronary syndromes. An ongoing, prospective, observational study. Am J Med 2004;117:73-81.
  3. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A. Avezum Á, Flather MD, Fox KAA, for the GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. J Am Med Assoc 2004;291:2727-33.
  4. Fox KAA. An international perspective on acute coronary syndrome care. Insights from the Global Registry of Acute Coronary Events. Am Heart J 2004;148:S40-5.
  5. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PhG, Gowda N, Gore JM, for the GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 2004;164:1457-63.
  6. Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum Á, López-Sendón J, Klein W, Mukherjee D, Eagle KA, Dabbous OH, Goldberg RJ, for the GRACE Investigators. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2004;147:42-8.
  7. Goldberg RJ, Currie K, White K, Brieger D, Steg PhG, Goodman SG, Dabbous O, Fox KAA, Gore JM. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2004;93:288-93.
  8. Mehta RH, Sadiq I, Goldberg RJ, Gore JM, Avezum Á, Spencer F, Kline-Rogers E, Allegrone J, Pieper K, Fox KAA, Eagle KA, for the GRACE Investigators. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J 2004;147:253-9.
  9. Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KAA, Granger CB, Mehta RH, Brieger D, for the GRACE Investigators. Association of statin therapy with outcomes of acute coronary syndromes: The GRACE Study. Annal Int Med 2004;140:857-66.
  10. Steg PhG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont M-C, López-Sendón J, Budaj A, Goldberg RJ, Klein W, Anderson FA, for the Global Registry of Acute Coronary Events (GRACE) Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004;109:494-9.
2003
  1. Budaj A, Brieger D, Steg PhG, Goodman SG, Dabbous OH, Fox KAA, Avezum Á, Cannon CP, Mazurek T, Flather MD, Van de Werf F, for the GRACE Investigators. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003;146:999-1006. [Summary]
  2. Fox KAA, Goodman SG, Anderson FA, Granger CB, Moscucci M, Flather MD, Spencer F, Budaj A, Dabbous OH, Gore JM, on behalf of the GRACE Investigators. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1414-24.
  3. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van de Werf F, Avezum Á, Goodman SG, Flather MD, Fox KAA, for the Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 2003;163:2345-53.
  4. Klein W, Kraxner W, Hödl R, Steg PhG, Budaj A, Gulba D, Sadiq I, Van de Werf F, White K, Fox KAA, for the GRACE investigators. Patterns of use of heparins in ACS. Correlates and hospital outcomes: the Global Registry of Acute Coronary Events (GRACE). Thromb Haemost 2003;90:519-27.
  5. Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA Jr, Fox KAA, Gore JM, Goldberg RJ, Eagle KA, for the GRACE Investigators. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 2003;92:1031-6.
  6. Montalescot G, Van de Werf F, Gulba DC, Avezum Á, Brieger D, Kennelly BM, Mazurek T, Spencer F, White K, Gore JM, for the GRACE Investigators. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the Global Registry of Acute Coronary Events (GRACE). Catheter Cardiovasc Interv 2003;60:360-7.
  7. Moscucci M, Fox KAA, Cannon CP, Klein W, López-Sendón J, Montalescot G, White K, Goldberg RJ, for the GRACE Investigators. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1815-23.
  8. Santopinto JJ, Fox KAA, Goldberg RJ, Budaj A, Piñero G, Avezum Á, Gulba D, Esteban J, Gore JM, Johnson J, Gurfinkel EP, on behalf of the GRACE Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Heart 2003;89:1003-8.
2002
  1. Dauerman HL, Goldberg RJ, White K, Gore JM, Sadiq I, Gurfinkel E, Budaj A, Lopez de Sa E, López-Sendón J, for the GRACE Investigators. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 2002;90:838-42.
  2. Eagle K. Lessons from GRACE: the Global Registry of Acute Coronary Events. Eur Heart J 2002;4(Suppl E):E24-31.
  3. Eagle KA, Goodman SG, Avezum Á, Budaj A, Sullivan CM, López-Sendón J, for the GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-7.
  4. Fox KAA, Goodman SG, Klein W, Brieger D, Steg PhG, Dabbous O, Avezum Á, for the GRACE Investigators. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-89.
  5. Goldberg RJ, Steg PhG, Sadiq I, Granger CB, Jackson EA, Budaj A, Brieger D, Avezum Á, Goodman S. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am J Cardiol 2002;89:791-6.
  6. Spencer F, Santopinto J, Gore JM, Goldberg RJ, Fox KAA, Moscucci M, White K, Gurfinkel EP. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2002;90:1056-61.
  7. Steg PhG, Goldberg RJ, Gore JM, Fox KAA, Eagle KA, Flather MD, Sadiq I, Kasper R, Rushton-Mellor SK, Anderson FA, for the GRACE Investigators. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002;90:358-63.
2001
  1. The GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001;141:190-9.
2000
  1. Fox KAA. An introduction to the Global Registry of Acute Coronary Events: GRACE. Eur Heart J 2000;2(Suppl F):F21-4.
  2. Granger CB. Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry. Am J Cardiol 2000;86(Suppl):4M-9M.

Validation of GRACE risk scores - non-GRACE publications

  1. Alter DA, Venkatesh V, Chong A. Evaluating the performance of the Global Registry of Acute Coronary Events risk-adjustment index across socioeconomic strata among patients discharged from the hospital after acute myocardial infarction. Am Heart J 2006;151:323-331.
  2. Bradshaw PJ, Ko DT, Newman AM, Donovan LR, Tu JV. Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post-discharge death in an independent data set. Heart 2006;92:905-909.
  3. de Araujo Goncalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005;26:865-872.
  4. Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007;153:29-35.
  5. Carmo PL, Ferreira JS, Aguiar CT, Goncalves PA, Raposo LF, Ferreira AM, Aniceto Silva JM. Does Continuous ST-Segment Monitoring Add Prognostic Information to the TIMI, PURSUIT, and GRACE Risk Scores? J Am Coll Cardiol 2008; 51(10, Suppl A):1024-84.

‘Expanded’ GRACE publications

  1. Philippe F, Larrazet F, Dibie A, Bouabdallah K, Carbognani D, Folliguet T, Czitrom D, Lagier A, Laborde F, Cohen A, Montalescot G. [Management of acute coronary syndromes in a new French coronary intensive care unit. The first four years of activity in the GRACE registry (Global Registry of Acute Coronary Events)]. Ann Cardiol Angeiol (Paris). 2005;54(2):68-73.
  2. Tebbe U, Bramlage P, von Löwis of Menar P, Lawall H, Gaudron P, Lüders S, Klaus A, Lengfelder W, Scholz KH, Maziejewski S, Cuneo A, Hohmann V, Gulba D. Behandlung des akuten koronarsyndroms in Deutschland: erfahrungen eines deutschen clusters des GRACE-registers. [Treatment of the acute coronary syndrome in Germany: experience in a German cluster of the GRACE registry]. Dtsch Med Wochenschr. 2007 Sep;132(39):2000-5.
GLOW | GRACE | STAT | DVT.org
GRACE is supported by an educational grant from sanofi aventis
Copyright 1998-2008 Center for Outcomes Research - University of Massachusetts Medical School
For general questions and information email: GRACE at umassmed.edu or call (508)856-0081